BIOMAT Database Logo BIOMAT Database Logo

Significant myoglobin removal during continuous veno-venous haemofiltration using F80 membrane. 1997

B Bastani, and D Frenchie

UI MeSH Term Description Entries
D008297 Male Males
D008567 Membranes, Artificial Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis (RENAL DIALYSIS), monomolecular and bimolecular membranes used as models to simulate biological CELL MEMBRANES. These membranes are also used in the process of GUIDED TISSUE REGENERATION. Artificial Membranes,Artificial Membrane,Membrane, Artificial
D009211 Myoglobin A conjugated protein which is the oxygen-transporting pigment of muscle. It is made up of one globin polypeptide chain and one heme group.
D001781 Blood Component Removal Any procedure in which blood is withdrawn from a donor, a portion is separated and retained, at the same time the remainder is returned to the donor. Apheresis,Pheresis,Aphereses,Blood Component Removals,Phereses,Removal, Blood Component
D006440 Hemofiltration Extracorporeal ULTRAFILTRATION technique without HEMODIALYSIS for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function. Arteriovenous Hemofiltration,Venovenous Hemofiltration,Arteriovenous Hemofiltrations,Hemofiltration, Arteriovenous,Hemofiltration, Venovenous,Hemofiltrations,Venovenous Hemofiltrations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

B Bastani, and D Frenchie
Heparin clearance during continuous veno-venous haemofiltration.
January 1994, Intensive care medicine,
B Bastani, and D Frenchie
DC cardioversion during continuous veno-venous haemofiltration.
February 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
B Bastani, and D Frenchie
Anticoagulation in continuous veno-venous haemofiltration.
January 2000, Nursing in critical care,
B Bastani, and D Frenchie
Elimination of amrinone during continuous veno-venous haemofiltration after cardiac surgery.
January 1995, European journal of clinical pharmacology,
B Bastani, and D Frenchie
[Continuous veno-venous haemofiltration in adult intensive therapy].
January 2011, Anestezjologia intensywna terapia,
B Bastani, and D Frenchie
Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
December 2000, European journal of clinical pharmacology,
B Bastani, and D Frenchie
Transfusion requirements during continuous veno-venous haemofiltration: -the importance of filter life.
November 2000, Intensive care medicine,
B Bastani, and D Frenchie
The impact of long-term haemofiltration (continuous veno-venous haemofiltration) on cell-mediated immunity during endotoxaemia.
July 2007, Acta anaesthesiologica Scandinavica,
B Bastani, and D Frenchie
Myoglobin clearance during continuous veno-venous hemofiltration with or without dialysis.
April 1998, The International journal of artificial organs,
B Bastani, and D Frenchie
Creatinine and urea clearance during continuous veno-venous haemofiltration in critically ill patients.
June 1996, Anaesthesia,
Copied contents to your clipboard!